Document Type
Poster
Presentation Date
5-30-2026
Abstract
Background/Research Objective
Cannabis is increasingly used to manage cancer-related symptoms including pain, sleep disturbance, anxiety, and appetite or gastrointestinal complaints. However, patient responses are highly variable, clinicians report limited confidence in guiding use, and optimal dosing is difficult to predict from baseline characteristics. We evaluated whether an iterative, guided cannabis care model incorporating ongoing patient feedback and care-plan adjustments is associated with improved symptom relief and lower side-effect burden in a real-world oncology population.
Recommended Citation
Worster, MD, Brooke; Parton, MBA, Kristen; and Garber, MSW, Gregory, "Iterative Cannabis Care Plans are Associated with Higher Rates of Symptom Relief and Lower Side-Effect Burden in Oncology Patients" (2026). Kimmel Cancer Center Papers, Presentations, and Grand Rounds. Paper 86.
https://jdc.jefferson.edu/kimmelgrandrounds/86
Language
English

Comments
Presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.